Alzheimer's Disease Trial, Recruiting NCT05977712 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05977712
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must be willing and able to sign a consent form agreeing to take part
  • You must be registered with the French social security system

Who may not be able to join:

  • You cannot take part if you have a skin allergy to plastic
  • You cannot take part if you have been diagnosed with a psychiatric condition that fully explains any memory or thinking problems you have
  • You cannot take part if you have significant cognitive (thinking or memory) difficulties and are unable to come to appointments with someone accompanying you, or if your doctor feels you need someone with you (for example, if you use a wheelchair or experience agitation) (confirm with trial site)
  • You cannot take part if you are already involved in another research study that could affect your body clock, either at the time of joining or during the 9-day period when you would be wearing a movement-tracking device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0140054313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 March 2024
Est. completion
1 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Dementia subtypes and stages (% at inclusion); Dementia subtypes and stages (incidence); Alzheimer's disease stages (%); Alzheimer's disease stages (change in)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov